LONDON (Alliance News) - ITV reported higher profits and revenues for 2013 and gave a bullish outlook for 2014, but has seen its shares punished Wednesday after it failed to increase its special dividend. The television company raised its total dividend for 2013 to 3.5 pence, from 2.6 pence Read More

UK WINNERS & LOSERS: Contrarian Price Moves For ITV And Weir Shares

26th Feb 2014 12:24

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday. ------- FTSE 100 - WINNERS Weir Group, up 6.5%. Despite reporting a fall in profit and revenue fo Read More

Clinigen Hikes Dividend As Pretax Profit Rises, On Track For Full-Year

26th Feb 2014 11:10

LONDON (Alliance News) - Clinigen Group PLC raised its interim dividend and said it was on track to meet full-year expectations, as it saw pretax profit rise in the half-year ended December 31, 2013. Clinigen posted an interim dividend of 1.0 pence per share, up from 0.6 pence in the previo Read More

UK MORNING BRIEFING: Shares Open Lower; ITV Down On Payout Level

26th Feb 2014 08:37

LONDON (Alliance News) - Shares have opened lower Wednesday ahead of UK GDP figures at 0930 GMT. ITV reported strong 2013 results and expressed confidence for 2014, but its shares are down 4.2% at the open on disappointment in the size of its special dividend. <br / Read More

UK Earnings, Trading Statements Calendar - Week Ahead

25th Feb 2014 17:00

UK Earnings, Trading Statements Calendar - Week Ahead

24th Feb 2014 16:17

UK Earnings, Trading Statements Calendar - Week Ahead

21st Feb 2014 16:08

UK Earnings, Trading Statements Calendar - Week Ahead

20th Feb 2014 16:36

UK Earnings, Trading Statements Calendar - Week Ahead

20th Feb 2014 06:18

UK Earnings, Trading Statements Calendar - Week Ahead

19th Feb 2014 16:00

Clinigen Extends Accord Deal To Include Chemotherapeutic Drug

14th Jan 2014 11:39

LONDON (Alliance News) - Clinigen Group PLC said Tuesday that its Clinical Trials Supply Business had extended its exclusive EU clinical trial distribution agreement with Accord Healthcare to include chemotherapeutic tablet capecitabine. Clinigen is the sole point of contract for all clinic Read More

FTSE 100 Latest

Value8,809.74

Change53.53